He [Dr. Bosch] smiled and quickly answered they couldn't comment on that but that DCVAX-L would be submitted like any other product is to the FDA [emphasis added].
This puts to bed the notion that NWBO spent the last year getting thing expedited at the FDA with rolling this or that. 'Would be' means that a submission hasn't started yet assuming that you heard him right (I have not had a chance to go to the audio).
None of this precludes getting a more rapid regulatory approval in the UK or on the continent but given how poorly the last year was used to strategize the TLD rollout, I would not expect that a ton of work was gotten out of the way with the regulators.